: Keros Therapeutics started at buy with $65 stock price target at BofA Securities

[This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.



2023-07-26 14:47:00

All news and articles are copyrighted to the respective authors and/or News Broadcasters. VIXC.Com is an independent Online News Aggregator


Read more from original source here…

About Author

Market News - RSS Feed

See author's posts